Company: PHAT
Filing Date: 2025-04-23
Form Type: DEF 14A
Source: 0000950170-25-057326
Chunk: 65

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-04-23
Form: DEF 14A
Chunk 65
---
 c/o Broadridge, 51 Mercedes Way, Edgewood, NY 11717.V67637-P29094 PHATHOM PHARMACEUTICALS, INC.The Board of Directors recommends you vote FOR each of the following director nominees:1.To elect two class III directors to hold office until the 2028 Annual Meeting of Stockholders. Nominees: For Withhold 1a.Heidi Kunz !! 1b. James Topper, M.D., Ph.D.!! The Board of Directors recommends you vote FOR the following proposals: For Against Abstain 2.To ratify the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending !!! December 31, 2025. 3.To approve the compensation of the named executive officers on a non-binding advisory basis ("say-on-pay"). !!! The Board of Directors recommends you vote 1 YEAR on the following proposal: 1 Year 2 Years 3 Years Abstain 4. To approve a proposal for the frequency of future non-binding advisory votes on the compensation of the named executive officers !!!! ("say-on-frequency"). NOTE: Such other business as may properly come before the meeting or any adjournment thereof. Please sign exactly as your name(s) appear(s) hereon. When signing as attorney, executor, administrator, or other fiduciary, please give full title as such. Joint owners should each sign personally. All holders must sign. If a corporation or partnership, please sign in full corporate or partnership name by authorized officer.

Important Notice Regarding the Availability of Proxy Materials for the Annual Meeting:The Annual Report and Notice and Proxy Statement are available atwww.proxyvote.com.PHATHOM PHARMACEUTICALS, INC. Annual Meeting of Stockholders June 3, 2025 11:30 AM EDT This proxy is solicited by the Board of Directors The stockholder(s) hereby appoint(s) Stevn Basta and Molly Henderson, or either of them, as proxies, each with the power to appoint his/her substitute, and hereby authorize(s) them to represent and to vote, as designated on the reverse side of this ballot, all of the shares of Common stock of PHATHOM PHARMACEUTICALS, INC. that the stockholder(s) is/are entitled to vote at the Annual Meeting of Stockholders to be held at 11:30 AM EDT on June 3, 2025, via live webcast by visiting www.virtualshareholder